Imagion Biosystems Limited
IBXXF
$0.01
-$0.025-71.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 83.63% | 66.05% | 47.70% | 16.23% | -21.32% |
| Total Depreciation and Amortization | -67.16% | -42.64% | -18.73% | -8.80% | 2.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.02% | -53.08% | -44.90% | -22.88% | 21.87% |
| Change in Net Operating Assets | -95.14% | 5.91% | 7,167.84% | 7,167.84% | 7,167.84% |
| Cash from Operations | 84.93% | 79.22% | 74.39% | 40.30% | 1.46% |
| Capital Expenditure | -- | 67.96% | 50.09% | 58.82% | 64.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 144.12% | 100.41% | 75.32% | 66.90% | 61.27% |
| Total Debt Issued | -79.43% | -67.67% | -51.20% | 88.80% | -- |
| Total Debt Repaid | 95.55% | 78.74% | 65.39% | 36.25% | -0.73% |
| Issuance of Common Stock | 31.15% | 82.05% | 373.79% | 939.89% | 85,007.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 68.96% | 51.26% | 19.26% | -161.47% | -- |
| Cash from Financing | -16.28% | 6.99% | 77.90% | 1,537.44% | 531.98% |
| Foreign Exchange rate Adjustments | 742.86% | -101.71% | -111.89% | -103.47% | -100.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 156.73% | 119.33% | 99.16% | 75.50% | 54.39% |
